Search

Your search keyword '"Bethany C. Prudner"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Bethany C. Prudner" Remove constraint Author: "Bethany C. Prudner"
33 results on '"Bethany C. Prudner"'

Search Results

1. Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress

2. Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer

3. miR-133a function in the pathogenesis of dedifferentiated liposarcoma

4. Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102

5. Supplementary Figure from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102

6. Data from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102

7. Supplementary Data from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102

8. Data from Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

10. Supplementary Data from SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

11. Supplementary Table from Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102

12. Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

13. Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1

14. Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives

16. Amino Acid Uptake Measured by [18F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas

18. Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers

19. Liposarcoma: molecular targets and therapeutic implications

20. Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma

22. Abstract CT111: Preclinical justification for the Phase II clinical trial ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma

23. A phase II study of ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma

24. p67/MetAP2 Suppresses K-RasV12-Mediated Transformation of NIH3T3 Mouse Fibroblasts in Culture and in Athymic Mice

25. A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas

26. SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

27. Abstract A11: Arginine deprivation alters global lipid metabolism in ASS1-deficient sarcomas

28. Propofol restores TRPV1 sensitivity via a TRPA1-, nitric oxide synthase-dependent activation of PKCε

29. HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)

30. α-Synemin localizes to the M-band of the sarcomere through interaction with the M10 region of titin

33. A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas

Catalog

Books, media, physical & digital resources